Paul J. Diaz
President and CEO at Myriad Genetics Inc.
Sits on 4 boards. Last updated September 28, 2026
Time on boards
- Boards served
- 4
- Current seats
- 4
- Board service
- 8 years
- Director since
- 2023
8 years of board service in total across 4 boards, counting each seat separately. Longest: Myriad Genetics Inc., 3 years.
Chief executive roles
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jul 28, 2026 | Centene Corporation | Grant or award | +2,771 | — | — |
| Mar 24, 2025 | Myriad Genetics Inc. | Shares withheld for tax | −18,312 | $9.98 | $182,754 |
| Mar 24, 2025 | Myriad Genetics Inc. | Shares withheld for tax | −26,827 | $9.98 | $267,733 |
| Mar 22, 2025 | Myriad Genetics Inc. | Shares withheld for tax | −19,859 | $10.01 | $198,789 |
| Mar 22, 2025 | Myriad Genetics Inc. | Shares withheld for tax | −52,682 | $10.01 | $527,347 |
| Mar 15, 2025 | Myriad Genetics Inc. | Shares withheld for tax | −30,118 | $10.07 | $303,288 |
| Mar 14, 2025 | Myriad Genetics Inc. | Shares withheld for tax | −37,564 | $10.07 | $378,269 |
| Feb 7, 2025 | Myriad Genetics Inc. | Grant or award | +114,828 | — | — |
| Oct 11, 2024 | Myriad Genetics Inc. | Open-market sale | −15,000 | $22.93 | $343,950 |
| Sep 11, 2024 | Myriad Genetics Inc. | Open-market sale | −15,000 | $26.72 | $400,800 |
| Aug 13, 2024 | Myriad Genetics Inc. | Shares withheld for tax | −22,808 | $28.18 | $642,729 |
| Aug 13, 2024 | Myriad Genetics Inc. | Shares withheld for tax | −50,980 | $28.18 | $1,436,616 |
| May 15, 2024 | Myriad Genetics Inc. | Open-market sale | −75,000 | $25.07 | $1,880,250 |
| May 14, 2024 | Myriad Genetics Inc. | Open-market sale | −95,000 | $25.21 | $2,394,950 |
| May 13, 2024 | Myriad Genetics Inc. | Open-market sale | −57,844 | $25.13 | $1,453,620 |
Questions about Paul J. Diaz
What boards is Paul J. Diaz on?
Paul J. Diaz sits on the boards of Centene Corporation, DaVita Inc., Merck & Company Inc. and Myriad Genetics Inc.
What company is Paul J. Diaz the CEO of?
Paul J. Diaz is President and CEO of Myriad Genetics Inc.
How long has Paul J. Diaz served on boards?
Our records show at least 8 years of board service across 4 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.